Spicy Tidbit: Pashmina v. Basmati


Here’s an encouraging article I came across recently. BBC News reports that India and Pakistan are working jointly to register a GI for Basmati rice. The implications of such cooperation are extremely profitable as Basmati accounts for more than half the rice consumed in Europe and the Middle East. As the Indian share in the Basmati market has increased in the past few years Pakistan has suffered and so this GI will be a real aid to their market share….


Read More »

"Patent" Journalist in India Wins Award


SpicyIP is extremely happy to learn that CH Unnikrishnan of the Mint, by far the most sophisticated “patent” reporter in India, recently won the “best reporter of the month” award. Although an internal award conferred by Mint, what is striking is that the award was specifically conferred for his articles on “patents”. Notably, the ones where he shook up the Indian patent office with his coverage on Roche’s Valcyte patent, where the patent office issued the patent without hearing the…


Read More »
Patent

SpicyIP Tidbit: Bruce Almighty.


If there’s a word that could conjure bigger and larger images of quantity other than “Whopping”, it could be “Colossal” or “Humongous”. Either ways, Dr.Bruce Saffran will smile his way to the bank thanks to $501 million he was awarded by jurors in the case against Boston Scientific Corp. in the patent infringement suit involving drug-coated heart stents. Saffran argued that the stents launched by Boston Scientific violated his 1997 patent on technology to deliver medication within the body to…


Read More »

SpicyIP Tidbit: Applying the brakes to TVS’s manufacture.


News about the spark plug crash is coming in fast and how! Reported just yesterday, the auto patent scene indeed seems to be heating up. In what is seen as a major setback to TVS, an interim order by the Madras High Court has restrained TVS from manufacturing and selling its new TVS Flame 125 bikes. An appeal by TVS’s lawyers seems almost inevitable now. For all those who don’t remember the exact nature of the dispute a look at…


Read More »

Digging deep for new developments: To harness the wealth of the ocean!


The Government of India on a new initiative has decided to bolster India’s position as one of the leaders in deep sea bed mining and provide a competitive edge for pharmaceutical companies in the development of new drugs. The Department of Earth Sciences has launched a new programme to harness new beneficial molecules from the sea for “therapeutic purposes”. Launched by the Government as a long term assignment, the programme is spearheaded by the Central Drug Research Institute, with the…


Read More »

And the fight gets dirtier.


In a follow up to a recent post on allegations of collusion between US drug companies and Indian pharma companies with regard to delaying the entry of generic drugs in the US market the US anti-competitive practices watch dog Federal Trade Commission has identified Ranbaxy amongst 4 other firms as being part of the ploy. It is alleged that these companies recieved in excess of $200 million to delay the entry of generic drugs into the US market till 2012…


Read More »

A spicy GI


SpicyIP has always had a natural tendency to report on the ‘spicier’ issues of IP law. So just imagine our excitement when we found out about Geographical Indication protection for spices. We however promise to refrain from over-using the ‘spicy’ puns that come to our minds. The latest is Assam’s ‘Karbi Anglong ginger’ which is well on track to receive GI protection. The district administration recently filed an application claiming GI protection for GIs. The Karbi Anglong ginger is supposed…


Read More »

SpicyIP Tidbit: Revving up Auto Patent Litigation


Finally, it seems like the Indian auto sector is catching up, albeit at its own pace, with its global counterparts not just in terms of technology, but also in litigations over technology. The Bajaj-TVS imbroglio couldn’t have started at a more “opportune” moment; an article from The Michigan Technology News has observed that litigations over auto patents are on the rise globally. Here’s the full article along with a podcast of an opinion maker. As an autobuff, I can’t decide…


Read More »

Spicy IP Tidbit: Indian Pharma companies seek 200% rebate


The Hindu reports that Indian pharma companies are seeking a 2oo% tax rebate on R&D. Read in conjunction with my recent post on Indian pharma companies entering into collaboration with foreign firms for research we see our pharma companies are intent to promote research in a big way. In its representation to Finance Ministry, industry chamber Indian Pharmaceutical Alliance (IPA) asserted that incentives in research and development (R&D) are required to boost the credentials of the sector from being a…


Read More »
Patent

Spicy IP Tidbit: Patent Reform in the USA, happy pharma companies in India


An interesting piece by Benedetto Della Vedova on the Patent Reform Act about to be passed in America. Read the full piece here. The relevance of this to us in India is that apart from the inclusion of the first to file approach is the introduction of the post-grant review process. Perhaps most damaging, the Patent Reform Act provides a post-grant review process that allows any patent to be challenged ad infinitum. This would increase costs for inventors and jeopardize…


Read More »